Vericel (VCEL) Accumulated Expenses (2010 - 2026)
Vericel (VCEL) reported Accumulated Expenses of $14.0 million for Q1 2026, up 22.32% on a YoY basis from $11.4 million in Q1 2025, and down 27.39% sequentially from $19.2 million in Q4 2025.
Vericel (VCEL) Accumulated Expenses (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Accumulated Expenses data on file, last reported at $14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 22.32% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2026 stood at $14.0 million (up 22.32% YoY), and the FY2025 full-year result was $19.2 million, up 12.72% from the prior year.
- Accumulated Expenses declined to $14.0 million in Q1 2026, from $19.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $19.2 million in Q4 2025 to a low of $10.8 million in Q1 2022.
- A 5-year average of $14.2 million and a median of $14.0 million in 2026 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses rose 27.59% in 2022 and slipped 15.9% in 2024, its largest moves.
- Tracing VCEL's Accumulated Expenses over 5 years: stood at $16.2 million in 2022, then climbed by 6.33% to $17.2 million in 2023, then decreased by 0.87% to $17.1 million in 2024, then grew by 12.72% to $19.2 million in 2025, then fell by 27.39% to $14.0 million in 2026.
- Business Quant data shows VCEL's Accumulated Expenses at $14.0 million in Q1 2026, $19.2 million in Q4 2025, and $16.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.97 Mn |
| Dec 31, 2025 | 19.24 Mn |
| Sep 30, 2025 | 16.29 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 11.42 Mn |
| Dec 31, 2024 | 17.07 Mn |
| Sep 30, 2024 | 14.34 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | 13.63 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 13.11 Mn |
| Dec 31, 2022 | 16.19 Mn |
| Sep 30, 2022 | 13.95 Mn |
| Jun 30, 2022 | 12.13 Mn |
| Mar 31, 2022 | 10.79 Mn |
| Dec 31, 2021 | 14.05 Mn |
| Sep 30, 2021 | 10.93 Mn |
| Jun 30, 2021 | 11.08 Mn |